DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20205642

T4 squamous cell cancer of buccal mucosa successfully treated combination of interstitial brachytherapy, concurrent chemo-radiotherapy and salvage surgery

Jyoti Sharma, Aman Sharma, Swati Verma

Abstract


We report a case of advanced case of right sided buccal mucosa deemed inoperable achieving long term cure with a combination of interstitial brachytherapy and concurrent chemoradiotherapy (CRT) followed by salvage surgery for small recurrence. The patients were considered for upfront double plane 12 catheter implant to a dose of 25 Gy in 8 fractions at the rate of 3.125 Gy per fraction. Two fractions were delivered in a day at least 6 hours apart. Thereafter patient was subjected to CRT to a dose of 40 Gy in 20 fractions. At follow up there was complete resolution of disease barring a small induration raw area at angle of mouth, which was successfully managed by salvage surgery. Patient is now on regular follow up for 18 months from completion of treatment and is disease free for 1 year.


Keywords


Buccal mucosa, Interstitial brachytherapy implant, CRT

Full Text:

PDF

References


Mathur P, Sathishkumar K. Report From National Cancer Registry Programme, India (National Centre for Disease Informatics and Research, Bengaluru, India). Cancer Statistics, 2020.

Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995;24(10):450-3.

grawal M, Pandey S, Jain S, Maitin S. Oral cancer awareness of the general public in Gorakhpur city, India. Asian Pac J Cancer Prev. 2012;13:5195-9.

Prisciandaro JI, Foote RL, Herman MG, Lee SJ, LaJoie WN, Van Blarcom AB et al. A buccal mucosa carcinoma treated with high dose rate brachytherapy. Journal of Applied Clinical Medical Physics. 2005;6:8-12.

Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870-6.

Puthawala A, Nisar Syed AM, Gamie S, Chen YJ, Londrc A, Nixon V. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. Int J Radiat Oncol Biol Phys. 2001;51(2):354-62